International Bladder Cancer Group

Nonprofit profile at a glance

EIN
932407167
IRS 990 coverage
2024–2025
Forms available
Form 990 2025
Location
Flemington, NJ, USA
Phone
5163596257
Rating
65
Verdict
SUPPORTED
Rating confidence
Moderate
Sector
Professional Societies, Associations

Reported finances

Revenue
$603,104
Expenses
$436,909
Assets
$248,123
Liabilities
$347

Source: IRS Form 990. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

3 people listed

Executive titles in this filing

  • Ashish Kamat MD (President)
  • Roger Buckley MD (Vice President)

People named in this filing

  • Ashish Kamat MD (President)
  • Roger Buckley MD (Vice President)
  • Prem Kumar Parameswaran (Treasurer)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The International Bladder Cancer Group (IBCG) is a globally recognized entity that has published numerous peer-reviewed articles addressing knowledge gaps in - and providing recommendations for - the management of bladder cancer.The IBCG was formed with a primary objective being to address global educational needs and learning gaps in order to improve the care and management of patients with urothelial carcinoma. The inaugural meeting, in 2006, consisted of members selected as representatives of their varied geographic regions across Europe, North America and Asia. The members were specifically selected not only for their expertise but also to ensure representation from across the globe.Over the years, the mission of the IBCG has been to improve outcomes of patients suffering from bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. An additional goal is to develop practical educational tools that are applicable to the global uro

What it reported doing in 2025

The IBCG has expanded its membership in the past few years to include many globally recognized experts in the field of bladder cancer. This expansion has included a wide range of health care professionals including medical oncologists, radiation oncologists, statisticians and researchers with representation to include all the continents. In 2021, the IBCG created a Health Services Research group led by Dr. Stephen B Williams which aims to be the collaborative source for clinicians and researchers. An IBCG newsletter under Chief Editor Dr. Fred Witjes was launched in Q1 2022. In August 2025, the IBCG held a retreat (#IBCG25) to discuss 2 very important topics: Biomarkers in Urothelial CancerToxicity of Local Therapies for Bladder CancerThis retreat led by our program chairs, Drs. Shilpa Gupta, Roger Li, and Patrick Hensley opened its doors to a wider audience with partners from industry invited to join the KOLs and patient advocates, and resulted in robust discussions directed towards improving care for our patients. Other activities include: AUA - IBCG Bladder Cancer Forum - held in 2022 ,2023, 2024 and 2025; IBCG collaboration with Mexican Urological Society to develop Mexican Bladder Cancer Guidelines; Collaborative effort between GSRGT and IBCG to tackle variant histology/histologic subtypes in bladder cancer. The IBCG will continue to support ongoing initiatives including clinical trial design, clinical research, national and international guideline assistance, and conference or symposium organization.

Operating model

Revenue model
Donor-supported. 100% of the money available for current operations came from contributions and gifts.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. A relatively small share of voting board members are independent and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 72
  • Transparency & Controls: 92
  • Accountability: 0
  • Sustainability: 63
  • Growth: 100

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 71.1%; rating input score 71
  • Program expense ratio: 98.2%; rating input score 98
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 63rd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: Yes; rating input score 100
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 0%; rating input score 0; 6th percentile among comparable filings
  • Governance controls: 0 of 7 controls in place; rating input score 0
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Fail
    • Board meeting minutes documented: Fail
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 27.6%; rating input score 80; 80th percentile among comparable filings
  • Total-asset coverage ratio: 0.57; rating input score 27; 27th percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 72; 72nd percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 78; 78th percentile among comparable filings

Growth

  • Program expense growth: 31.9% per year; rating input score 100; 89th percentile among comparable filings
  • Revenue growth: 42.3% per year; rating input score 100; 94th percentile among comparable filings
  • Asset growth: 87.2% per year; rating input score 100; 98th percentile among comparable filings

Details

  • Where the money goes: 71.1% of revenue deployed · 98.2% of spending went to programs
  • Governance: 0 of 3 board members independent · 0 of 7 filing controls reported
  • Programs: 1 filed program accomplishment · $429K in reported program spending
  • Leadership: top reported pay $0 · 3 people listed
  • Consistency: 17 of 17 current checks pass
  • Schedules: 4 filed schedules · includes major donors
  • Filing history: 2 filing years from 2024 to 2025
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Accountability: Independent voting board scored 0/100.
  • High — Accountability: Governance controls: 6 of 6 not reported.
  • High — Sustainability: Total-asset coverage ratio scored 27/100.